Northwest Biotherapeutics (NWBO) Construction in Progress (2015 - 2017)

Northwest Biotherapeutics' Construction in Progress history runs 3 years deep, the most recent figure standing at $47.3 million for Q4 2017.

• In Q4 2017, Construction in Progress rose 6.19% year-over-year to $47.3 million; the TTM figure through Dec 2017 stood at $47.3 million (up 6.19% YoY), while the FY2017 annual figure was $47.3 million, up 6.19% from the prior year.
• Construction in Progress for Q4 2017 stood at $47.3 million, roughly flat from $47.3 million in the prior quarter.
• The five-year high for Construction in Progress was $47.3 million in Q3 2017, with the low at $44.6 million in Q4 2016.
• The 3-year median for Construction in Progress is $46.0 million (2015), against an average of $46.0 million.
• The sharpest annual moves came in 2016 and 2017: Construction in Progress declined 2.46% in 2016, then gained 6.19% in 2017.
• Northwest Biotherapeutics' Construction in Progress stood at $45.7 million in 2015, then declined by 2.46% to $44.6 million in 2016, then increased by 6.19% to $47.3 million in 2017.
• Business Quant data shows NWBO's Construction in Progress at $47.3 million in Q4 2017, $47.3 million in Q3 2017, and $46.2 million in Q2 2017.